secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ovid Therapeutics Inc. (OVID)
CIK:        0001636651
Form:       8-K
Filed at:   2026-04-20T23:59:59+00:00
Accession:  0001628280-26-025926
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Ovid Therapeutics receives $53.9M from exercise of Series A warrants; issues 33.6M common shares
--------------------------------------------------------------------------------

- Series A warrants from Oct 2025 private placement expired on April 17, 2026; 38,481,325 underlying shares.
- Investors exercised 33,597,860 shares at $1.40 each and 4,883,464 pre-funded warrants at $1.399 each.
- Gross proceeds of approximately $53.9 million to the company.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1636651/000162828026025926/0001628280-26-025926-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1636651/000162828026025926/ovid-20260420.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-025926

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer